Antimicrobial, Angiogenic Skin Substitutes for Diabetic*
Small Business Information
505 SOUTH ROSA ROAD, SUITE 169, MADISON, WI, 53719
AbstractDESCRIPTION (provided by applicant): The goal of this application is to develop a genetically engineered therapeutic human skin substitute with enhanced antimicrobial and angiogenenic properties for use in the treatment of type 1 diabetic skin ulcers.
* information listed above is at the time of submission.